Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Nature 448:561-6 (2007)
DOI:10.1038/nature05945

Bayliss R, Choi J, Fennell DA, Fry AM, Richards MW

Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs.

Cell Mol Life Sci 73:1209-24 (2016)
DOI:10.1007/s00018-015-2117-6

Sasaki T, Okuda K, Zheng W, Butrynski J, Capelletti M, Wang L, Gray NS, Wilner K, Christensen JG, Demetri G, Shapiro GI, Rodig SJ, Eck MJ, Janne PA

The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers.

Cancer Res 70:10038-43 (2010)
DOI:10.1158/0008-5472.CAN-10-2956